Correction to: Leukemia https://doi.org/10.1038/s41375-021-01374-3
In the original article, the publisher missed to include the final contribution statement.
Caroline Rolfes and Thomas Wiesmann contributed equally to this paper as senior authors.
The original article has been updated.
Co-last authors Caroline Rolfes, Thomas Wiesmann
About this article
Cite this article
Neubauer, A., Johow, J., Mack, E. et al. Publisher Correction: The janus-kinase inhibitor ruxolitinib in SARS-CoV-2 induced acute respiratory distress syndrome (ARDS). Leukemia (2021). https://doi.org/10.1038/s41375-021-01412-0